What are the existing options for Endometriosis?

Endometriosis affects roughly 10% (190 million) of reproductive-age women and girls around the world. These figures may be under-represented as there is limited awareness about endometriosis from patients and healthcare workers.

Who is the study for?

Patients with Endometriosis living in Victoria, Australia

What will patients be taking in this study?

In this study you will be assigned to one of three groups : 

• Group 1 will receive cannabidiol (CBD) oil

• Group 2 will receive CBD oil + vaourised (i.e., inhaled) cannabis flower

• Group 3 will receive placebo oil

Eligibility Criteria

• Have endometriosis (confirmed either via laproscopy, MRI or ultrasound)

• Live in Victoria

• Are 20 years of age or older

• Presented to the emergency department for symptoms related to your endometriosis 2 or more times in the past 6 months

What are the benefits for participating?

Participation in this study may help you to manage symptoms of endometriosis. However, please be aware that since there are no previous similar studies of medicinal cannabis in endometriosis, there may be no direct benefit to you from participating in this study. While the intervention we are testing was found useful in other patient populations, there is no guarantee it will be effective in people with endometriosis. However, this project may benefit the wider endometriosis community. It is likely to provide necessary data to design better treatments for people with endometriosis.

Please note that you will not be able to drive a car for up to 4 months while participating in the study. Your participation is voluntary, and you may stop at any time.